High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.

Source:http://linkedlifedata.com/resource/pubmed/id/18197066

Download in:

View as

General Info

PMID
18197066